https://www.avient.com/industries/healthcare/medical-packaging/nutraceutical-packaging
Soft touch TPEs for overmolded caps that allow consumers to open products more easily
Idea Center: TPE Videos, Case Studies, and More
Learn all the ways TPEs are being used to enhance performance and appeal Explore TPES in our Idea Center
https://www.avient.com/resources/safety-data-sheets?page=3388
BLUE 1
BROWN T045-3-1 TPE
TR RUBY RED T085-2-1 TPE
https://www.avient.com/sites/default/files/2023-01/Mevopur Colorants _ Additives Brochure.pdf
COMPREHENSIVE REGULATORY TESTING AND DOCUMENTATION Raw materials tested to: • ISO 10993-1 and USP , (biological evaluation) • European Pharmacopeia 3.1.3/3.1.5 (polyolefin —materials used for the manufacture of containers) • USP (polyethylene—plastic materials of construction) • ICH Q3D (elemental impurities) We provide Drug Master File (Type III) documentation and other supporting regulatory declarations that are relevant for the application.
Mevopur products cover the wide range of polymers and thermoplastic elastomers (TPEs) used in the medical and pharmaceutical sectors.
https://www.avient.com/sites/default/files/2022-11/AVNT Q3 2022 Earnings Presentation - Website Final.pdf
Pro Forma Financial Information The Company acquired Avient Protective Materials (“Dyneema”) on September 1, 2022 (the “Acquisition Date”) and sold the Distribution segment on November 1, 2022.
Purchase price multiple rapidly declining on strength of business and synergy capture 7 $133 $201 2019PF 2022E 7 Clariant Color EBITDA Growth Purchase Price Multiple 10.8x 7.0x 6.4x 2019PF 2021 2022E w/ Full Synergies (1) (1) 11.9% 16.3% 2019PF 2022E EBITDA Margins (1) CLARIANT COLOR: TRANSFORMATIONAL ACQUISITION ($ in millions) (1) Financial information is pro forma to include a full year of Clariant Color business SUNBELT PVC Resins DSS 20 Acquisitions $4.8B Investment $2.7B of Annual Revenue 5 Divestments $2.3B Proceeds TPE PP&S HISTORIC SPECIALIZATION THROUGH M&A 8 Distribution DSM Protective Materials BOLT-ON ACQUISITION HISTORY 9 Commercial Resources Operating Income ($ in millions) Operating Margins 259 363 At Acquisition 2022E $40 $139 At Acquisition 2022E 9% 22% At Acquisition 2022E Established Acquisitions (> 7 years) + 40% + 248% + 1300 bps I N V E S T T O G R O W SPECIALTY TRANSFORMATION T O D A Y 7% 46% 67% 86% 100% 0% 20% 40% 60% 80% 100% 2005 2010 2019 2021 2022 PF % o f A d ju st ed E B IT D A • Commodity JVs • Distribution • Performance Products & Solutions • Specialty Businesses (1) Adjusted EBITDA is EBITDA excluding corporate costs and special items (2) Pro forma for the acquisition of Dyneema® and divestiture of Distribution (1 ) (2) 10 Healthcare 4% Packaging 8% Consumer 10% Building & Construction 43% Industrial 15% Transportation 14% Energy 4% Telecom. 2% 2006 2022 Pro Forma Healthcare 8% Packaging 23% Consumer 21% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% Defense 6% END MARKET FOCUS ON LESS CYCLICAL INDUSTRIES 11 14.8% 17.6% 21.0% 2018 2020 2022 PF 1.8% 2006 15.3% 16.2% 17.0% 2018PF 2020PF 2022E CAI 2.7% 2006 SEM SPECIALTY EBITDA MARGIN EXPANSION 12 • Portfolio transformation accelerates growth in less cyclical, higher margin end markets • Investments in our composites platform continue to drive margin expansion (1) (1) (1) 2018 and 2020 financial information is pro forma to include a full year of Clariant Color acquisition PORTFOLIO EVOLUTION OVER THE YEARS 13 Adj.
The Q3 2022 "Pro Forma APM" adjustments reflect periods prior to the acquisition date and are preliminary estimates for APM’s results for the months of July and August. 2 Reconciliation of Avient consolidated pro forma EBITDA Q3 2022 Q3 2021 Avient(1) Pro forma APM(1) Pro forma Avient Avient Pro forma APM Pro forma Avient Net income from continuing operations (27.8) 3.9 (23.9) 33.4 0.3 33.7 Income tax expense (1.2) 0.6 (0.6) 2.0 2.5 4.5 Interest expense 37.3 1.8 39.1 19.0 11.2 30.2 Depreciation and amortization 39.8 10.9 50.7 36.6 18.4 55.0 EBITDA 48.1 17.2 65.3 91.0 32.4 123.4 Special items, before tax 82.0 — 82.0 19.9 — 19.9 Interest expense included in special items (10.0) — (10.0) — — — Depreciation included in special items (0.8) — (0.8) (0.9) — (0.9) Adjusted EBITDA $ 119.3 $ 17.2 $ 136.5 $ 110.0 $ 32.4 $ 142.4 (1) - Q3 2022 Avient results reflect one month of APM’s results while owned by Avient, as the acquisition closed on September 1, 2022.
https://www.avient.com/resources/safety-data-sheets?page=6736
TRL ORANGE 172C TPE
TPE BACHELOR BUTTON
ET6000-0006 HI UV ARMY GREEN NM 1
https://www.avient.com/resources/safety-data-sheets?page=6271
TPE BLACK ADAPTER
TPE UNIVERSAL BLACK CMPD
ET6000-0006 HI UV Desert Sand 1
https://www.avient.com/resources/safety-data-sheets?page=6437
TPE MEDIUM BLUE 7682C
XHC-35689-0004A-01-1
TPE WHITE DIAMOND
https://www.avient.com/sites/default/files/2020-07/versaflex-hc-syringe-plunger-spanish.pdf
Versaflex HC - Syringe Plunger - Spanish FABRICANTE DE JERINGAS É M B O L O D E J E R I N G A D E S E C H A B L E • Cumplir con las normas USP VI e ISO 10993-4,5 • Esterilización con gamma y EtO • Rendimiento de sellado a largo plazo • Bajo coeficiente de fricción (COF) • Rendimiento uniforme en jeringas de diferentes diámetros • Ofreció una solución formulada que cumple con los requerimientos rigurosos de una aplicación médica • Mejoró la continuidad del suministro global • Aumentó la eficiencia del proceso al sustituir el material termoestable anterior con un TPE Versaflex™ HC 2110-57B REQUERIMIENTOS CLAVE ¿POR QUÉ AVIENT?
https://www.avient.com/sites/default/files/2021-10/versaflex-top-cover-of-air-cushion-powder-case-study-one-pager.pdf
Cosmetic brands COSMETIC BRANDS C O V E R O F A I R C U S H I O N P O W D E R C O M P A C T • Low coefficient of friction (COF) to balance the opening pressure and sealing performance • General FDA compliance • Good chemical resistance and barrier protection to water and oxygen • Overmold to PP with good compression set • Delivered chemically resistant material with excellent sealing properties and good resilience to achieve requested performance • Provided onsite technical support to improved injection speed and achieve good bonding performance • Offered a material solution that could be leveraged across the customer’s global cosmetic brands Custom Versaflex™ TPE KEY REQUIREMENTS WHY AVIENT?
https://www.avient.com/sites/default/files/2020-07/onflex-interior-trays-spanish.pdf
OnFlex - Interior Trays - Spanish PROVEEDOR TIER 2 B A N D E J A S I N T E R I O R E S • Un material con bajo FOG y olor bajo • Acabado semi-mate • Facilidad de procesamiento • Permitió un procesamiento más sencillo que el existente TPE-V • Se eliminó el paso de pre-secado y el material se entregó pre-coloreado, lo que mejoró la eficiencia del proceso • Cumple con las necesidades de bajo FOG (≤2 mg) y poco olor (≤3.0), con acabado semi-mate OnFlex™ S EH 80A-3S7005 REQUERIMIENTOS CLAVE SOLUCIÓN AVIENT CUMPLE CON LAS NORMAS VIAQ MÁS INFORMACIÓN Copyright © 2020, Avient Corporation.